首页|空间代谢组学在医药领域的应用及挑战

空间代谢组学在医药领域的应用及挑战

扫码查看
生物体内代谢物的变化对于反映疾病的发生和发展过程及药物的作用机制、毒性具有重要意义.空间代谢组学是基于质谱成像的一门新技术,可直接从组织中获得代谢物的各种信息.它与传统代谢组学相比,具有周期短、无需基质、免标记等优势,规避了传统代谢组学损失空间信息的瓶颈.该技术应用范围涵盖肿瘤、代谢性疾病、感染性疾病的分型、诊疗、预后评估,以及药物、药用活性成分研究.然而,空间代谢组学也存在一系列不足之处,如分辨率和灵敏度的相互制约关系、精确鉴定和定量检测的局限性.空间代谢组学的发展有望推动药物改良、促进合理用药.
Applications and challenges of spatial metabolomics in the pharmaceutical field
Changes of metabolites within organisms are crucial for reflecting disease occurrence,progression,drug mechanisms,and toxicity.Spatial metabolomics,a novel technology based on mass spectrometry imaging,can directly obtain various metabolite information from tissues.Compared to traditional metabolomics,it offers advantages such as shorter cycles,no need for matrices,and label-free analysis,overcoming the spatial information loss bottleneck of traditional methods.The technology is applicable in areas like tumor,metabolic,and infectious disease classification,diagnosis,prognosis evaluation,as well as drug and bioactive component research.However,spatial metabolomics faces several limitations,including the trade-off between resolution and sensitivity,and the challenges in precise identification and quantitative detection.Despite these challenges,spatial metabolomics is expected to evolve through exploration,potentially driving drug improvements and promoting rational drug use.

spatial metabolomicsmass spectrometrydisease diagnosis and treatmentdrugsbottlenecks and challenges

舒子芹、王琦

展开 >

哈尔滨医科大学药学院药物化学与天然药物化学教研室,哈尔滨 150081

空间代谢组学 质谱 疾病诊疗 药物 瓶颈与挑战

2024

临床与病理杂志
中南大学

临床与病理杂志

CSTPCD
影响因子:0.559
ISSN:1673-2588
年,卷(期):2024.44(5)